Features Partner Sites Information LinkXpress
Sign In

Radiosurgery Suite Receives US Clearance for Noninvasive Surgical Procedures

By Medimaging International staff writers
Posted on 20 Feb 2013
Print article
Image: The Edge radiosurgery suite (Photo courtesy of Varian Medical Systems).
Image: The Edge radiosurgery suite (Photo courtesy of Varian Medical Systems).
A new dedicated radiosurgery system has been developed for performing radiosurgery using real-time tumor tracking and motion management technologies.

Varian Medical Systems (Palo Alto, CA, USA) has received US Food and Drug Administration (FDA) 510(k) clearance for the company’s Edge radiosurgery suite. “The Edge suite represents a new paradigm in radiosurgery, offering clinicians a system that combines Varian’s world-class technologies in an end-to-end solution for planning and delivering radiosurgery treatments,” said Chris Toth, vice president of marketing for Varian’s oncology systems business. “It integrates Varian’s state-of-the-art radiosurgery technology with tools for real-time imaging, tracking, and patient positioning. It enables fast, accurate delivery of stereotactic radiosurgery for treating lesions, tumors, and conditions anywhere in the body where radiotherapy is indicated, including tumors of the lung, prostate, spine, and brain.”

Recent FDA 510(k) clearances cover the following technologies that are integrated into the Edge radiosurgery suite. These new technologies are also being made available as upgrades to other compatible Varian systems: The PerfectPitch couch, which is an integrated 6° of freedom (6DoF) treatment couch that provides the precision, accuracy, and flexibility required to position patients optimally, adjust their position to correct for any misalignments, and support them comfortably during treatment. The couch has been designed for the accuracy and functionality required to provide radiosurgery treatments in the brain and in the rest of the body.

The advanced motion and image-guided radiotherapy (IGRT) package is a sophisticated motion management package that offers clinicians many options for using real-time imaging during radiotherapy treatments. It also enables expanded use of fluoroscopy and four-dimensional (4D) cone-beam computed tomography (CT)—imaging techniques that show motion over time—to better compensate for tumor motion during treatment.

The intracranial radiosurgery package is an integrated set of technologies for planning and delivering stereotactic radiosurgery treatments for tumors or functional abnormalities in the brain. The intracranial radiosurgery package supports the accurate delivery of radiation using multiple beam-shaping options, including Varian's high-definition multileaf collimator and radiosurgery conical collimators, and is compatible with both frame-based and frameless patient immobilization approaches.

Lastly, the Calypso system, which has several enhancements, have been incorporated into the Calypso system for real time tracking. The system utilizes transponders, or position signaling devices, that are implanted in or around a tumor, or placed on the surface of the body and monitored to track motion during treatment. New enhancements increase the rate of transponder signal processing in order to track faster types of motion, such as respiratory motion, in real time. The system is also compatible with the couch rotations that are frequently employed to optimize targeting during treatments in the lung. The technology also includes updated usability features designed to streamline treatments and optimize the user experience.

One optional Edge suite subcomponent is still pending FDA 510(k) clearance: Calypso anchored Beacon transponders for implantation in the lung to guide lung radiosurgery procedures.

Related Links:

Varian Medical Systems

Print article



view channel

Additional Aggressive Cancers Can Be Found Using Breast MRI Following Mammography Screening

The results of a study published online in the journal Radiology have shown that performing MRI scans, after the discovery of mammography breast cancer findings, sometimes shows larger and more aggressive tumors than those discovered in mammography. Breast Magnetic Resonance Imaging (MRI) is widely used for the screening... Read more


view channel

Fast, Noninvasive Assessment of Chronic Liver Disease Announced as Alternative to Biopsies

A leading ultrasound imaging vendor has presented the clinical benefits of its innovative technology for noninvasive assessment of the severity of liver fibrosis, at the Liver Meeting 2015, in San Francisco (CA, USA). Researchers have published more than 60 items on the reliability and effectiveness of the new technology.... Read more

Nuclear medicine

view channel
Image: Glioblastoma in a PET scanner with (left) and without (right) the YY146 marker (Photo courtesy of Weibo Cai, WISC).

Antibody Cancer Marker Causes Tumors to Light Up

A novel marker attaches to a molecule on highly aggressive brain cancer, resulting in glioblastoma tumor tissue being easily identified in a positron emission tomography (PET) scanner. Developed by... Read more

Imaging IT

view channel
Image: 3D scan a child’s heart born with congenital heart defects (Photo courtesy of the Phoenix Children’s Hospital).

3D Modeling System Accurately Predicts Pediatric Donor Heart Volumes

A new three dimensional (3D) computer modeling system may more accurately identify the best donor heart for a pediatric transplant patient. To develop the new 3D system, researchers at Arizona State... Read more

Industry News

view channel

Long-Term Strategic Managed Medical Equipment Services Partnership Announced

An 18-year strategic collaboration agreement, worth CAD 300 million, between a major medical imaging vendor and the Southwest York Region of Ontario in Canada, has been announced. The partnership is for managed equipment services to help advance medical technology in the Southwest York region, and to expand the accessibility... Read more
Copyright © 2000-2015 Globetech Media. All rights reserved.